1413 related articles for article (PubMed ID: 26140482)
81. Sensitizing brain metastases to stereotactic radiosurgery using hyperbaric oxygen: A proof-of-principle study.
Hartford AC; Gill GS; Ravi D; Tosteson TD; Li Z; Russo G; Eskey CJ; Jarvis LA; Simmons NE; Evans LT; Williams BB; Gladstone DJ; Roberts DW; Buckey JC
Radiother Oncol; 2022 Dec; 177():179-184. PubMed ID: 36404528
[TBL] [Abstract][Full Text] [Related]
82. Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.
Ahluwalia M; Barnett GH; Deng D; Tatter SB; Laxton AW; Mohammadi AM; Leuthardt E; Chamoun R; Judy K; Asher A; Essig M; Dietrich J; Chiang VL
J Neurosurg; 2018 May; 130(3):804-811. PubMed ID: 29726782
[TBL] [Abstract][Full Text] [Related]
83. Stereotactic radiosurgery in elderly patients with brain metastases.
Minniti G; Esposito V; Clarke E; Scaringi C; Bozzao A; Lanzetta G; De Sanctis V; Valeriani M; Osti M; Enrici RM
J Neurooncol; 2013 Feb; 111(3):319-25. PubMed ID: 23187817
[TBL] [Abstract][Full Text] [Related]
84. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract][Full Text] [Related]
85. Clinical Results and Hematologic Predictors of Linear Accelerator-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis in Patients Aged 75 Years or Older: A Retrospective Study.
Matsuda R; Hasegawa M; Tamamoto T; Inooka N; Morimoto T; Maeoka R; Nakazawa T; Ochi T; Miyasaka T; Hontsu S; Yamaki K; Miura S; Yamada S; Nishimura F; Nakagawa I; Park YS; Nakase H
World Neurosurg; 2024 Mar; 183():e944-e952. PubMed ID: 38244685
[TBL] [Abstract][Full Text] [Related]
86. Does Stereotactic Radiosurgery Have a Role in the Management of Patients Presenting With 4 or More Brain Metastases?
Soike MH; Hughes RT; Farris M; McTyre ER; Cramer CK; Bourland JD; Chan MD
Neurosurgery; 2019 Mar; 84(3):558-566. PubMed ID: 29860451
[TBL] [Abstract][Full Text] [Related]
87. Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases.
Leeman JE; Clump DA; Wegner RE; Heron DE; Burton SA; Mintz AH
Radiat Oncol; 2012 Jul; 7():107. PubMed ID: 22784482
[TBL] [Abstract][Full Text] [Related]
88. Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
Churilla TM; Ballman KV; Brown PD; Twohy EL; Jaeckle K; Farace E; Cerhan JH; Anderson SK; Carrero XW; Garces YI; Barker FG; Deming R; Dixon JG; Burri SH; Chung C; Ménard C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1173-1178. PubMed ID: 28939223
[TBL] [Abstract][Full Text] [Related]
89. A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases.
Hanson PW; Elaimy AL; Lamoreaux WT; Demakas JJ; Fairbanks RK; Mackay AR; Taylor B; Cooke BS; Thumma SR; Lee CM
World J Surg Oncol; 2012 Aug; 10():176. PubMed ID: 22931379
[TBL] [Abstract][Full Text] [Related]
90. Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.
Ma R; Levy M; Gui B; Lu SE; Narra V; Goyal S; Danish S; Hanft S; Khan AJ; Malhotra J; Motwani S; Jabbour SK
J Neurooncol; 2018 Jan; 136(2):395-401. PubMed ID: 29159778
[TBL] [Abstract][Full Text] [Related]
91. Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review.
Goyal S; Silk AW; Tian S; Mehnert J; Danish S; Ranjan S; Kaufman HL
JAMA Oncol; 2015 Aug; 1(5):668-76. PubMed ID: 26181286
[TBL] [Abstract][Full Text] [Related]
92. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
[TBL] [Abstract][Full Text] [Related]
93. Reduced Mortality and Radiation Necrosis After Surgery With Postoperative Stereotactic Radiation in Patients With Multiple Brain Metastases.
Bhave VM; Lamba N; Tjong MC; Aizer AA; Bi WL
Neurosurgery; 2024 Jan; 94(1):117-128. PubMed ID: 37489905
[TBL] [Abstract][Full Text] [Related]
94. Single-fraction radiosurgery of benign cavernous sinus meningiomas.
Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
J Neurosurg; 2013 Sep; 119(3):675-82. PubMed ID: 23808540
[TBL] [Abstract][Full Text] [Related]
95. Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases.
Albers EAC; de Ruiter MB; van de Poll-Franse LV; Merckel LG; Compter A; Schagen SB
J Neurooncol; 2022 Dec; 160(3):649-658. PubMed ID: 36454373
[TBL] [Abstract][Full Text] [Related]
96. Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain Metastases.
Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
JAMA Oncol; 2023 Aug; 9(8):1066-1073. PubMed ID: 37289451
[TBL] [Abstract][Full Text] [Related]
97. Factors associated with progression and mortality among patients undergoing stereotactic radiosurgery for intracranial metastasis: results from a national real-world registry.
Alvi MA; Asher AL; Michalopoulos GD; Grills IS; Warnick RE; McInerney J; Chiang VL; Attia A; Timmerman R; Chang E; Kavanagh BD; Andrews DW; Walter K; Bydon M; Sheehan JP
J Neurosurg; 2022 Oct; 137(4):985-998. PubMed ID: 35171833
[TBL] [Abstract][Full Text] [Related]
98. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control.
Alvarez-Breckenridge C; Giobbie-Hurder A; Gill CM; Bertalan M; Stocking J; Kaplan A; Nayyar N; Lawrence DP; Flaherty KT; Shih HA; Oh K; Batchelor TT; Cahill DP; Sullivan R; Brastianos PK
Oncologist; 2019 May; 24(5):671-679. PubMed ID: 30796152
[TBL] [Abstract][Full Text] [Related]
99. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer.
Noel G; Medioni J; Valery CA; Boisserie G; Simon JM; Cornu P; Hasboun D; Ledu D; Tep B; Delattre JY; Marsault C; Baillet F; Mazeron JJ
Lung Cancer; 2003 Sep; 41(3):333-43. PubMed ID: 12928124
[TBL] [Abstract][Full Text] [Related]
100. Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
Tang JD; Mills MN; Nakashima J; Dohm AE; Khushalani NI; Forsyth PA; Vogelbaum MA; Wuthrick EJ; Yu HM; Oliver DE; Liu JKC; Ahmed KA
J Neurooncol; 2024 Feb; 166(3):431-440. PubMed ID: 38310157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
